Clinical Partners Limited, a leading provider of mental health treatment, has successfully acquired the Oxford ADHD & Autism Centre, solidifying its position in the neurodevelopmental and mental health services sector.
As one of the largest independent providers in the UK, Clinical Partners offers comprehensive neurodevelopmental and mental health services to both the NHS and private sectors. With a workforce of over 400 professionals nationwide, Clinical Partners annually supports approximately 40,000 patients. The company is experiencing rapid growth and the acquisition of Oxford ADHD highlights its commitment to expanding its capabilities to serve a broader population.
Established in 2015 by Dr Polly Branney, the Oxford ADHD & Autism Centre specialises in diagnosing and providing support for individuals, both children and adults, with neurodevelopmental disorders and related conditions. With a dedicated team of around 40 specialists, the clinic’s staff will now join Clinical Partners.
Dr Alice Parshall, Chief Medical Officer of Clinical Partners, expressed her enthusiasm for the acquisition, stating, “We are thrilled to welcome our colleagues from the Oxford ADHD Centre to Clinical Partners. Polly and her team have built a reputation as a trusted and high-quality provider in the Oxford area, and we share a common commitment to delivering safe and effective services. We look forward to collaborating and leveraging our combined experience and expertise to further enhance our services for patients and their families.”
Dr Polly Branney, the founder of Oxford ADHD, explained her motivation for establishing the clinic eight years ago, citing the need for increased support in the local community for individuals with autism and ADHD. Over the years, the clinic has successfully treated over 3,000 patients and collaborated with several NHS services to facilitate access to expert support for both children and adults.
Recognising the challenges faced as an independent clinic amid rising demand, Dr. Branney acknowledged the potential for greater effectiveness and growth as part of a larger organisation. She believes that Clinical Partners is an ideal fit and expressed her well wishes for the next chapter in Oxford ADHD’s mission.
The acquisition of the entire share capital of Oxford ADHD by Clinical Partners was finalised on June 20, 2023, for an undisclosed amount. CapEQ (M&A) provided advisory services to Oxford ADHD, with legal counsel from Freeths. Keystone Law offered legal advice to Clinical Partners.
Mark Sapsford, Director of CapEQ, commented, “In today’s world, access to mental health support is crucial, and we are proud to have facilitated this transaction. We extend our best wishes to both parties as they merge their businesses to provide even more effective support and treatment in the Thames Valley and beyond.”
Malin Svanberg Larsson, partner at Freeths, stated, “We are delighted to have played a part in facilitating this transaction for Polly and the team at Oxford ADHD. We wish both parties continued success as they deliver invaluable mental health support to patients in the NHS and private sector.”
